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Malignant tumours of the fallopian tube are very
rare. The most common histological type is high-
grade serous adenocarcinoma. Sarcomas occur infre-
quently and carcinosarcomas or malignant mixed
Müllerian tumours (MMMTs) are extremely rare
(0.1–0.5% of all gynaecological malignancies, with
only about 60 cases reported in the literature).1–3
MMMTs, by definition, contain malignant
stromal and epithelial elements. They are character-
istically high-grade, have aggressive behaviour and
poor prognosis.3
Given its rarity and location, the definitive diag-
nosis of primary fallopian tube MMMT is difficult
to perform and to prove, and in the great majority
of cases the diagnosis remains uncertain until the
histological evaluation (ovarian tumour is the most
frequent preoperative and intraoperative diagnosis).
The authors describe the case of a 68-year-old
primiparous woman with a progressive increase in
abdominal volume and pelvic pain for 3 months. The
patient had no postmenopausal vaginal bleeding or
hydrorrhoea. An abdominopelvic CT revealed a
20×18 cm heterogeneous swelling with irregular
borders, an imperceptible starting point and large
volume ascites (figure 1). On suspicion of uterine
sarcoma, laparotomy was performed, with the possi-
bility of debulking surgery (total hysterectomy, bilat-
eral salpingo-oophorectomy and omentectomy). The
histological examination revealed a MMMT of the
fallopian tube assessed as FIGO (International
Federation of Gynaecology and Obstetrics) stage IIa
(figure 2). The patient underwent chemotherapy
with carboplatin and paclitaxel (6 cycles) and com-
plementary radiotherapy, which was interrupted due
to disease progression. Subsequently it was decided
to begin treatment with liposomal doxorubicin (2
cycles), but the patient died 12 months after being
diagnosed with a massive pelvic recurrence.
Learning points
▸ The diagnosis of extremely rare clinical
conditions requires a high degree of suspicion
(not only clinically and radiographically, but
also histologically).
▸ The existence of primary cancer of the fallopian
tube is often difficult to prove and only
histology can solve the challenge of definitive
diagnosis of these neoplasias.
▸ Most patients with malignant mixed Müllerian
tumours of the fallopian tube present with
non-specific abdominal symptoms of pain and
distension and/or atypical spotting, vaginal
bleeding or hydrorrhoea.1–3
Figure 1 Abdominopelvic CT findings ((A): tumour; (B): ascites).
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Figure 2 Microscopic findings (H&E
staining). These images clearly
demonstrate the diagnosis of primary
malignant mixed Müllerian tumour of
the fallopian tube (A). A tumour mass
is seen occupying the entire tubal
lumen (B) with malignant epithelial
component (C) and sarcomatous
components (D) with heterologous
elements of liposarcoma (E) and
chondrosarcoma (F) and the neoplasia
is lined by tubal epithelium (G).
Furthermore, there is only neoplastic
involvement of the outer surface of
both ovaries (H) and uterine body’s
serosa, the ovarian/uterine contribution
is to a lesser extent than in the
fallopian tube and there is no
coexistent endometrial cancer of the
same histological type.
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